USMLE Step 2 Quiz: Chronic Pediatric Conditions

What this quiz covers

This quiz focuses on Chronic Pediatric Conditions, giving you a quick way to practice the rules, question types, and explanations that matter most for USMLE Step 2.

How to use this quiz

Try each quiz question before looking at the correct answer. Use the explanations to review missed ideas, then come back to similar questions until the pattern feels familiar.

Question 1

1. Refer for evaluation of pulmonary valve intervention based on symptoms and right ventricular changes (correct answer)
2. Start inhaled bronchodilators for presumed asthma-related exercise intolerance
3. Defer cardiology follow-up until adulthood if oxygen saturation is normal
4. Begin chronic anticoagulation without evidence of arrhythmia or thrombosis
5. Recommend complete bed rest for 4 weeks to reverse right ventricular dilation

Explanation: This question tests USMLE Step 2 CK competencies in managing chronic pediatric conditions, focusing on repaired Tetralogy of Fallot. Effective management involves referral for valve intervention assessment. In this vignette, reduced exercise tolerance, RV dilation, moderate regurgitation, and sports participation highlight the management challenges and considerations for repaired Tetralogy of Fallot. Choice A is correct because it aligns with current clinical guidelines for evaluating symptomatic regurgitation. Choice C is incorrect because deferring follow-up risks progression. To improve understanding, clinicians should monitor for surgical indications, focusing on key management principles like activity guidance and imaging.

Question 2

1. Increase bedtime glargine dose to prevent nocturnal lows
2. Reduce basal insulin dose and reassess overnight glucose trends with more frequent monitoring (correct answer)
3. Stop all insulin for 24 hours to reset insulin sensitivity
4. Add sulfonylurea to reduce insulin requirements
5. Switch to sliding-scale insulin only without basal coverage

Explanation: This question tests USMLE Step 2 CK competencies in managing chronic pediatric conditions, focusing on type 1 diabetes. Effective management involves basal insulin adjustments based on trends. In this vignette, morning hypoglycemia, good HbA1c, increased activity, and smaller dinners highlight the management challenges and considerations for type 1 diabetes. Choice B is correct because it aligns with current clinical guidelines for reducing basal dose to prevent lows. Choice A is incorrect because increasing glargine would worsen hypoglycemia. To improve understanding, clinicians should review logs frequently, focusing on key management principles like activity adjustments and overnight monitoring.

Question 3

1. Recommend increased dietary phosphate intake to improve bone health
2. Reinforce low-phosphate diet, optimize phosphate binder adherence, and coordinate with a renal dietitian (correct answer)
3. Start high-dose vitamin A supplementation for pruritus
4. Order emergent dialysis solely for elevated phosphorus with stable kidney function
5. Stop all binders and treat symptoms with antihistamines only

Explanation: This question tests USMLE Step 2 CK competencies in managing chronic pediatric conditions, focusing on chronic kidney disease (CKD). Effective management involves dietary control and binder adherence for hyperphosphatemia. In this vignette, pruritus, bone aches, elevated phosphorus, PTH, skipped binders, and high-phosphate diet highlight the management challenges and considerations for CKD. Choice B is correct because it aligns with current clinical guidelines for low-phosphate diet and binder optimization. Choice A is incorrect because increasing phosphate worsens bone disease. To improve understanding, clinicians should involve dietitians for counseling, focusing on key management principles like electrolyte monitoring and symptom management.

Question 4

1. Increase lunchtime bolus insulin to prevent postprandial hyperglycemia
2. Reduce or delay pre-exercise bolus insulin and ensure a carbohydrate snack before activity (correct answer)
3. Stop basal insulin on practice days
4. Add metformin as first-line therapy for exercise-related hypoglycemia
5. Recommend skipping soccer to avoid hypoglycemia

Explanation: This question tests USMLE Step 2 CK competencies in managing chronic pediatric conditions, focusing on type 1 diabetes. Effective management involves insulin adjustments for activity and nutrition. In this vignette, hypoglycemia during soccer, postprandial lows, and short lunch periods highlight the management challenges and considerations for type 1 diabetes. Choice B is correct because it aligns with current clinical guidelines for reducing pre-exercise insulin and adding snacks. Choice E is incorrect because skipping activity limits physical health benefits. To improve understanding, clinicians should teach glucose monitoring around exercise, focusing on key management principles like individualized dosing and school coordination.

Question 5

1. Start erythropoietin immediately without addressing iron deficiency
2. Treat iron deficiency with tolerated iron regimen and dietary counseling before considering erythropoiesis-stimulating therapy (correct answer)
3. Order emergent dialysis to correct anemia
4. Recommend avoiding all protein to improve kidney function and anemia
5. Stop ACE inhibitor because it is the most likely cause of iron deficiency

Explanation: This question tests USMLE Step 2 CK competencies in managing chronic pediatric conditions, focusing on chronic kidney disease (CKD). Effective management involves correcting iron deficiency before advanced therapies. In this vignette, anemia symptoms, low Hb, iron indices, stable creatinine, vegetarian diet, and missed iron due to nausea highlight the management challenges and considerations for CKD. Choice B is correct because it aligns with current clinical guidelines for treating iron deficiency first. Choice A is incorrect because starting erythropoietin without iron ignores the primary cause. To improve understanding, clinicians should provide tolerable iron options, focusing on key management principles like nutritional counseling and anemia staging.

Question 6

1. Decrease basal insulin dose by 20% to reduce hypoglycemia risk
2. Stop mealtime insulin and use sliding-scale insulin only
3. Initiate a structured diabetes education plan with school support and adjust bolus dosing based on carb counting (correct answer)
4. Order abdominal CT to evaluate for pancreatitis as a cause of hyperglycemia
5. Recommend a strict low-carbohydrate diet without insulin changes

Explanation: This question tests USMLE Step 2 CK competencies in managing chronic pediatric conditions, focusing on type 1 diabetes. Effective management involves insulin therapy, carbohydrate counting, education, and addressing psychosocial barriers. In this vignette, wide glucose swings, high HbA1c, skipped meals, inconsistent carb counting, and school embarrassment highlight the management challenges and considerations for type 1 diabetes. Choice C is correct because it aligns with current clinical guidelines for structured education and school support to improve adherence and bolus dosing. Choice A is incorrect because decreasing basal insulin would not address the root causes of swings from missed boluses and poor carb counting. To improve understanding, clinicians should involve multidisciplinary teams for education and psychosocial support, focusing on key management principles like consistent monitoring and individualized plans. Additionally, empowering patients with school accommodations can enhance long-term control.

Question 7

1. Treat metabolic acidosis by improving alkali therapy adherence using a tolerable regimen and close follow-up (correct answer)
2. Increase dietary acid load with high-protein supplements to boost growth
3. Stop all CKD medications because growth issues are unrelated
4. Order emergent dialysis solely for bicarbonate of 16 mEq/L
5. Start chronic NSAIDs to improve appetite and energy

Explanation: This question tests USMLE Step 2 CK competencies in managing chronic pediatric conditions, focusing on chronic kidney disease (CKD). Effective management involves optimizing alkali therapy for acidosis. In this vignette, poor growth, low energy, low bicarbonate, stable creatinine, skipped tablets, and limited funds highlight the management challenges and considerations for CKD. Choice A is correct because it aligns with current clinical guidelines for improving adherence to correct acidosis. Choice B is incorrect because increasing acid load worsens growth issues. To improve understanding, clinicians should explore alternative formulations, focusing on key management principles like growth monitoring and cost-effective care.

Question 8

1. No further follow-up is needed if the child feels well
2. Schedule regular congenital cardiology surveillance and provide clear, language-appropriate follow-up instructions (correct answer)
3. Start daily digoxin for pulmonary regurgitation
4. Begin empiric antibiotics for endocarditis prophylaxis daily
5. Recommend complete sports restriction for life without additional assessment

Explanation: This question tests USMLE Step 2 CK competencies in managing chronic pediatric conditions, focusing on repaired Tetralogy of Fallot. Effective management involves regular surveillance and clear communication. In this vignette, asymptomatic status, missed follow-up, moderate regurgitation, RV enlargement, and instruction misunderstandings highlight the management challenges and considerations for repaired Tetralogy of Fallot. Choice B is correct because it aligns with current clinical guidelines for lifelong cardiology monitoring. Choice A is incorrect because ongoing follow-up is essential despite well-being. To improve understanding, clinicians should use simple language and reminders, focusing on key management principles like complication prevention and patient education.

Question 9

1. Ambulatory ECG monitoring to evaluate for ventricular arrhythmias (correct answer)
2. Abdominal ultrasound to evaluate for dehydration
3. Chest CT to evaluate for pulmonary embolism as the likely cause
4. Routine urinalysis to evaluate for kidney disease as the primary cause
5. No testing is needed if echocardiogram is unchanged

Explanation: This question tests USMLE Step 2 CK competencies in managing chronic pediatric conditions, focusing on repaired Tetralogy of Fallot. Effective management involves arrhythmia evaluation in symptomatic patients. In this vignette, palpitations, near-syncope, stable echo, and transportation barriers highlight the management challenges and considerations for repaired Tetralogy of Fallot. Choice A is correct because it aligns with current clinical guidelines for ambulatory ECG to detect ventricular arrhythmias. Choice E is incorrect because testing is warranted despite stable echo given symptoms. To improve understanding, clinicians should facilitate access to monitoring, focusing on key management principles like rhythm surveillance and prompt intervention.

Question 10

1. Reassure and schedule follow-up in 2 years because resting oxygenation is normal
2. Start daily furosemide and restrict all physical activity indefinitely
3. Arrange timely cardiology evaluation for pulmonary valve replacement consideration and obtain ambulatory rhythm monitoring (correct answer)
4. Order chest CT angiography as the first test to evaluate palpitations
5. Begin aspirin therapy solely to improve exercise tolerance

Explanation: This question tests USMLE Step 2 CK competencies in managing chronic pediatric conditions, focusing on repaired Tetralogy of Fallot. Effective management involves lifelong cardiology surveillance, monitoring for complications like pulmonary regurgitation, and addressing access barriers. In this vignette, reduced exercise tolerance, palpitations, severe pulmonary regurgitation, RV dilation, and missed visits due to transportation highlight the management challenges and considerations for repaired Tetralogy of Fallot. Choice C is correct because it aligns with current clinical guidelines for timely evaluation for valve replacement and rhythm monitoring in symptomatic patients. Choice A is incorrect because reassurance without intervention ignores progressive symptoms and risks further deterioration. To improve understanding, clinicians should emphasize regular follow-up and symptom recognition, focusing on key management principles like early intervention for arrhythmias and valvular issues.

Question 11

1. Recommend routine dental care and clarify that antibiotic prophylaxis is only indicated for specific high-risk cardiac lesions/procedures (correct answer)
2. Start daily antibiotics indefinitely to prevent endocarditis
3. Avoid all dental procedures permanently
4. Order blood cultures now to screen for endocarditis despite no symptoms
5. Begin anticoagulation before dental visits to prevent infection

Explanation: This question tests USMLE Step 2 CK competencies in managing chronic pediatric conditions, focusing on repaired Tetralogy of Fallot. Effective management involves targeted endocarditis prophylaxis education. In this vignette, stable status, delayed dental care, and parental concerns about infection highlight the management challenges and considerations for repaired Tetralogy of Fallot. Choice A is correct because it aligns with current clinical guidelines limiting prophylaxis to high-risk cases. Choice B is incorrect because daily antibiotics are unnecessary and promote resistance. To improve understanding, clinicians should promote preventive care, focusing on key management principles like risk stratification and hygiene.

Question 12

1. Step up to medium-dose inhaled corticosteroid or add LABA and counsel on trigger reduction (correct answer)
2. Stop controller therapy and rely on albuterol as needed
3. Begin long-term antibiotics for presumed chronic bronchitis
4. Order chest CT before any escalation of asthma medications
5. Start daily oral prednisone as first-line step-up therapy

Explanation: This question tests USMLE Step 2 CK competencies in managing chronic pediatric conditions, focusing on asthma. Effective management involves therapy escalation and trigger mitigation. In this vignette, frequent symptoms, reduced FEV1, confirmed adherence, and new dog exposure highlight the management challenges and considerations for asthma. Choice A is correct because it aligns with current clinical guidelines for stepping up ICS or adding LABA in persistent asthma. Choice B is incorrect because stopping controllers would exacerbate symptoms. To improve understanding, clinicians should counsel on environmental controls, focusing on key management principles like stepwise therapy and allergen avoidance.

Question 13

1. Echocardiography to evaluate for aortic root dilation (correct answer)
2. Bone age radiograph to assess epiphyseal closure
3. Abdominal ultrasound to screen for polycystic kidney disease
4. Oral glucose tolerance test to detect insulin resistance

Explanation: Turner syndrome requires lifelong monitoring for several associated complications, but cardiovascular abnormalities pose the greatest immediate risk and require the most urgent screening attention. Echocardiography to evaluate for aortic root dilation (A) is correct because cardiovascular complications are the leading cause of morbidity and mortality in Turner syndrome patients. Up to 50% develop bicuspid aortic valve, and progressive aortic root dilation can lead to life-threatening dissection. With this patient's elevated blood pressure (130/82 mmHg), cardiovascular screening becomes even more critical. Current guidelines recommend echocardiography every 5-10 years in adults, but more frequently if abnormalities are detected. Bone age radiograph (B) would be irrelevant at age 16 with established estrogen replacement therapy, as growth potential assessment is no longer clinically useful. Abdominal ultrasound for polycystic kidney disease (C) isn't indicated because Turner syndrome is associated with structural renal abnormalities like horseshoe kidney, not polycystic kidney disease. An oral glucose tolerance test (D) could eventually be considered since Turner patients have increased diabetes risk, but the glucose level was normal just one year ago, making this less urgent than cardiovascular screening. The elevated blood pressure in this case serves as an additional red flag that makes cardiovascular evaluation the top priority. Study tip: For Turner syndrome questions on Step 2, always prioritize cardiovascular screening first. Remember the "heart hierarchy" - when multiple screening options are presented for Turner patients, cardiovascular complications trump other concerns due to their potential for sudden, life-threatening consequences.

Question 14

1. Refer for evaluation for laparoscopic sleeve gastrectomy as a bariatric option (correct answer)
2. Prescribe orlistat 120 mg three times daily before high-fat meals
3. Begin metformin 500 mg twice daily to decrease hepatic steatosis
4. Increase exercise prescription to at least 2 hours of vigorous activity daily

Explanation: When evaluating severe pediatric obesity with significant comorbidities, you need to consider the full spectrum of treatment options, including bariatric surgery for carefully selected adolescents who meet specific criteria. This patient meets several key criteria for bariatric surgery consideration: BMI >35 kg/m² with serious comorbidities (obstructive sleep apnea requiring CPAP, hypertension, and NAFLD), Tanner stage III indicating adequate pubertal development, and failure of comprehensive lifestyle interventions over 18 months. Current guidelines support bariatric surgery evaluation in adolescents meeting these strict criteria. Answer A is correct because laparoscopic sleeve gastrectomy is an appropriate first-line bariatric procedure for adolescents. Answer B is incorrect because orlistat is not FDA-approved for children under 12 years old, and even when used in adolescents, it typically produces only modest weight loss (3-5%) with significant gastrointestinal side effects. Answer C is wrong because while metformin might help with insulin resistance, it's not a primary obesity treatment and won't address this patient's severe weight-related comorbidities that require more aggressive intervention. Answer D is inappropriate because demanding 2 hours of vigorous daily exercise is unrealistic for a morbidly obese child with sleep apnea and could lead to injury or treatment failure. Remember that pediatric bariatric surgery isn't a first-line treatment—it's reserved for severe cases with significant comorbidities after lifestyle interventions have failed. Always look for the combination of extreme BMI, serious health consequences, pubertal maturity, and failed conservative management when considering surgical options.

Question 15

1. Continue current management and recheck tTG IgA in another 6 months (correct answer)
2. Order small-bowel capsule endoscopy to assess for refractory sprue
3. Begin oral budesonide to hasten mucosal healing
4. Perform HLA typing (DQ2/DQ8) to confirm genetic susceptibility

Explanation: When managing pediatric celiac disease, you need to understand that serologic normalization typically lags behind clinical improvement by months to years, especially in children. The key indicators of treatment success are clinical response (symptom resolution and growth), not immediate serologic normalization. This patient demonstrates excellent clinical response: she's gained weight (1.8 kg), grown in height (4 cm), and her diarrhea has resolved after 6 months on a gluten-free diet. Her tTG IgA has improved significantly from 15 times normal to 5 times normal, showing a downward trend. These findings indicate the treatment is working effectively. Answer A is correct because continued monitoring is appropriate given the positive clinical trajectory. Serologic markers can take 12-24 months or longer to normalize, particularly in children with initially very high levels. Answer B is wrong because refractory sprue is diagnosed only after 12+ months of strict gluten-free diet without clinical improvement. This patient has clear clinical improvement, making refractory disease unlikely. Answer C is incorrect because corticosteroids like budesonide aren't indicated in typical celiac disease management. They're reserved for refractory cases or severe malabsorption that doesn't respond to dietary management alone. Answer D is wrong because HLA typing (DQ2/DQ8) is used for ruling out celiac disease in unclear cases, not for confirming treatment response. The diagnosis is already established, and genetic testing won't change management. Study tip: In celiac disease management, prioritize clinical response over serologic normalization. Antibody levels can remain elevated for months despite successful treatment, especially in pediatric patients.

Question 16

1. Check varicella immunity by serology and defer live vaccines indefinitely once biologics begin
2. Administer the 23-valent pneumococcal polysaccharide vaccine (PPSV23) for enhanced coverage (correct answer)
3. Provide quadrivalent conjugate meningococcal group B vaccine series initiation
4. Defer all additional vaccines because TNF-α inhibitors completely impair vaccine response

Explanation: When managing patients starting TNF-α inhibitors like infliximab, you must prioritize vaccination strategies that maximize protection while accounting for immunosuppression. These patients have increased infection risk, particularly from encapsulated bacteria and opportunistic pathogens. The correct approach is administering PPSV23 (answer B). TNF-α inhibitors significantly impair immune responses to Streptococcus pneumoniae, making pneumococcal disease prevention critical. PPSV23 provides broader serotype coverage (23 vs 13 serotypes in PCV13) and should be given before starting biologics when possible, as vaccine efficacy decreases once immunosuppression begins. Answer A contains a critical error - while checking varicella immunity is appropriate, you shouldn't "defer live vaccines indefinitely." Live vaccines should be avoided during biologic therapy but can be given before starting treatment if immunity is lacking. Answer C suggests meningococcal B vaccine, but this patient already received meningococcal conjugate vaccine. While MenB could be considered, pneumococcal vaccination takes higher priority given the specific pneumococcal infection risk with TNF-α inhibitors. Answer D is completely wrong - TNF-α inhibitors don't "completely impair" vaccine responses. While responses are diminished, vaccination (especially with inactivated vaccines) still provides meaningful protection and is strongly recommended. Key strategy: For biologic therapy questions, remember the vaccination hierarchy: complete all indicated inactivated vaccines before starting treatment, with pneumococcal vaccines being highest priority for TNF-α inhibitor patients. Live vaccines must be avoided during therapy but can be given beforehand if needed.

Question 17

1. Arrange a school-based directly observed therapy program for daily controller inhaler administration (correct answer)
2. Switch to a higher potency inhaled corticosteroid–long-acting β2-agonist combination
3. Provide home nebulizer therapy with budesonide twice daily
4. Schedule monthly clinic visits to reinforce adherence verbally

Explanation: When you encounter pediatric asthma cases with poor control despite appropriate medications, always consider adherence barriers first. This 9-year-old shows classic signs of medication non-adherence: frequent oral steroid courses, suboptimal prescription refills, and a working mother who cannot supervise daily medication use. Choice A is correct because it directly addresses the root problem—inconsistent medication administration. School-based directly observed therapy ensures the child receives daily controller medication during school hours when the mother cannot supervise. This intervention removes the primary barrier to adherence while maintaining the child's current appropriate medication regimen. Choice B is wrong because stepping up therapy intensity without addressing adherence won't improve outcomes and increases cost and side effect risk. The current medication is appropriate; the issue is consistent use, not potency. Choice C (home nebulizer) doesn't solve the supervision problem—the mother still cannot ensure twice-daily administration due to her work schedule. Additionally, switching delivery methods without addressing adherence is unlikely to improve control. Choice D (monthly verbal reinforcement) is too passive and doesn't provide practical solutions for the family's structural barriers. Simply telling someone to take medication more consistently doesn't address the underlying obstacle of maternal unavailability. Key strategy: In pediatric medication adherence questions, look for interventions that address specific logistical barriers rather than simply intensifying treatment. School-based programs are particularly effective for working families where parental supervision is limited during traditional medication times.

Question 18

1. Increase to medium-dose inhaled corticosteroid monotherapy while continuing as-needed albuterol
2. Add a long-acting inhaled β2-agonist in a fixed-dose combination with his current low-dose corticosteroid (correct answer)
3. Begin a leukotriene-receptor antagonist and discontinue the inhaled corticosteroid
4. Start oral theophylline in addition to the current low-dose inhaled corticosteroid

Explanation: When managing pediatric asthma, you need to assess current control and follow stepwise treatment guidelines. This patient shows signs of inadequate control despite being on Step 2 therapy: daytime symptoms 4 days/week (should be ≤2 days), nocturnal awakenings twice monthly (should be ≤1/month), and peak flow at 70% of personal best (should be >80%). The correct approach is B) Add a long-acting inhaled β2-agonist in a fixed-dose combination with his current low-dose corticosteroid. This represents Step 3 therapy per NHLBI guidelines. The combination of low-dose ICS + LABA is more effective than increasing ICS dose alone and has become the preferred step-up approach for inadequate control on low-dose ICS monotherapy. A represents an alternative Step 3 option, but medium-dose ICS monotherapy is less effective than the ICS/LABA combination and associated with higher risk of growth suppression in children. C is inappropriate because leukotriene receptor antagonists are less effective than ICS as controller therapy. You never discontinue effective controller medication (his ICS) when stepping up treatment. D suggests theophylline, which has a narrow therapeutic window, significant drug interactions, and side effects. It's considered an alternative add-on therapy only when preferred options aren't suitable. Study tip: Remember the asthma stepwise approach - when control is inadequate on low-dose ICS, the preferred step-up is adding LABA, not increasing ICS dose. Always assess control using the triad: symptoms, night awakenings, and peak flow/FEV1.

Question 19

1. Decrease nightly insulin glargine dose to 10 units and continue current lispro dosing (correct answer)
2. Keep glargine dose the same and reduce pre-breakfast lispro by 50%
3. Increase bedtime carbohydrate intake without changing insulin doses
4. Shift the timing of glargine from bedtime to before dinner while keeping the 12-unit dose

Explanation: When managing pediatric diabetes, you need to match each insulin component to the glucose pattern it's meant to control. Basal insulin (like glargine) controls overnight and fasting glucose, while bolus insulin (like lispro) manages post-meal spikes. This patient shows a clear pattern: consistently low fasting glucose (60-65 mg/dL) with normal daytime readings and appropriate bedtime levels (130-150 mg/dL). The fasting hypoglycemia indicates her basal insulin dose is too high for her overnight needs. Since her daytime control is good and she's not experiencing dangerous nocturnal hypoglycemia, a modest reduction in glargine is the safest approach. Answer A correctly reduces the glargine dose by about 17% (from 12 to 10 units), which should eliminate the fasting hypoglycemia while maintaining adequate overnight coverage. The lispro dosing remains unchanged since daytime glucose control is appropriate. Answer B incorrectly targets the breakfast bolus when the problem is overnight basal coverage. Reducing morning lispro would worsen post-breakfast glucose control without addressing the fasting hypoglycemia. Answer C uses food to treat a medication dosing problem. Adding bedtime carbohydrates might temporarily prevent hypoglycemia but doesn't fix the underlying insulin excess and could lead to weight gain. Answer D changes timing without addressing the dose. The 12-unit dose would still be excessive, just shifted earlier, and might actually worsen the problem by providing peak insulin action during sleep. Key strategy: In diabetes management questions, always match the insulin type (basal vs. bolus) to the problematic glucose timing. Fasting issues = basal insulin adjustment needed.

Question 20

1. Inhaled hypertonic saline administered twice daily
2. Daily azithromycin taken orally three times per week (correct answer)
3. High-dose ibuprofen therapy adjusted to serum levels
4. Itraconazole given orally for 6 months to eradicate fungal colonization

Explanation: When you encounter a cystic fibrosis patient with recurrent Pseudomonas exacerbations, think about chronic anti-inflammatory and antimicrobial therapies that can reduce exacerbation frequency rather than just treating acute infections. This patient has classic CF with frequent Pseudomonas exacerbations despite standard care. Azithromycin taken three times weekly (option B) is the correct addition because it provides anti-inflammatory effects that reduce pulmonary exacerbations in CF patients chronically infected with Pseudomonas. Multiple studies show azithromycin significantly decreases exacerbation rates and improves lung function, making it a standard recommendation for CF patients with chronic Pseudomonas colonization. Option A (inhaled hypertonic saline) can improve mucus clearance and lung function, but it's typically used earlier in CF management and is less effective than azithromycin for reducing exacerbation frequency in established Pseudomonas infection. Option C (high-dose ibuprofen) does have anti-inflammatory benefits in CF, but it requires careful monitoring for renal and GI toxicity, making it less commonly used than azithromycin. The dosing also needs precise serum level adjustment, which is challenging. Option D (itraconazole) targets fungal infections like Aspergillus, but this patient's problem is bacterial (Pseudomonas) exacerbations, not fungal colonization. For Step 2 CF questions, remember the hierarchy: start with airway clearance and pancreatic enzymes, then add chronic azithromycin for recurrent Pseudomonas exacerbations. Azithromycin's anti-inflammatory properties, not just its antibiotic effects, make it uniquely beneficial in CF.